News | January 06, 2010

ACNM, SNM to Hold Joint Nuclear Medicine Conference

January 6, 2010 - The American College of Nuclear Medicine (ACNM) is holding its annual meeting Jan. 27-28, 2010, in Albuquerque, N.M., in conjunction with the Society of Nuclear Medicine's (SNM) Mid-Winter Meeting.

The meeting, which provides attendees with the opportunity to earn up to 25 continuing education credits, will highlight the latest advancements in molecular imaging and nuclear medicine. The educational sessions will conclude with special workshops on nanomedicine and clinical trials.

The ACNM meeting will offer presentations on PET/CT of the head and neck, including thyroid cancer, chest and abdomen. ACNM will also offer lectures on the use of molecular imaging for lung scans and brain imaging and the use of new PET radiopharmaceuticals for treating disease. For nuclear medicine and radiology residents, ACNM will offer abstract presentations and a session on how to find a job in nuclear medicine.

SNM will offer a two-day CT case review workshop that will provide 16 hours of continuing education credit for physicians. SNM will also offer workshops on the use of molecular imaging for the diagnosis of neurodegenerative disorders, and diagnosis and treatment of heart failure. Sessions will take place Jan. 29-31.

SNM's Technologist Section (SNMTS) will host "The Sharp Edges of Nuclear Medicine: See What's New," Jan. 30-31,2010, to introduce technologists to new techniques in fusion imaging, with a focus on patients with epilepsy. SNMTS will also host a joint session with the American Society of Radiologic Technologists, focusing on legislative and regulatory issues facing nuclear medicine today, including USP and the Medicare Improvement Providers and Patients Act of 2008 (MIPPA).

SNM's Molecular Imaging Center of Excellence will host its annual summit on Jan. 31 and Feb. 1. This year's summit will focus on nanomedicine and molecular imaging. More than 20 experts from a variety of fields will examine current and potential uses of nanomaterials for patient care through improved diagnosis and individualized treatment strategies.

The week will cap off with SNM's Clinical Trials Workshop (CTN), Feb. 1-2, 2010. The CTN Workshop will expand on last year's successful meeting through in-depth presentations and discussions about how to expedite drug discovery, gain approval for new biomarkers, and comply with regulatory requirements in the U.S. and abroad. Featured seminars will cover the need for standardization in imaging trials, clinical research operating procedures, quality assurance, phantom utilization and good manufacturing practices. The CTN will host a special roundtable on the evening of Feb. 1 for leadership and senior staff at clinical research organizations. The CTN will also host sessions especially for nuclear medicine technologists about professional development opportunities in clinical trials research.

For more information: www.snm.org

Related Content

RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...
ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
A 3-D printed tungsten pre-clinical X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one hold out who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.

Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly e
University of Alabama at Birmingham Leading Production of Theranostic Radioisotope

Image courtesy of the University of Alabama at Birmingham

News | Radiopharmaceuticals and Tracers | August 29, 2019
The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne...
United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...